These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5267594)

  • 41. [Intermittent hemodialysis in terminal chronic nephropathy in Fredericia Hospital].
    Birkeland SA; Hoffmeyer J; Rojel J
    Ugeskr Laeger; 1969 Mar; 131(12):511-9. PubMed ID: 5793607
    [No Abstract]   [Full Text] [Related]  

  • 42. [Problems about the management of active pulmonary tuberculosis patients undergoing haemodialysis--our experiences and nation-wide questionnaire survey].
    Tomioka H; Tada K; Ohyama A; Fujiyama R; Ohnishi H; Sakurai T; Sakamoto H; Nishiguchi H; Yamamoto T; Sakashita T; Shirai C; Iwasaki H
    Kekkaku; 2003 Apr; 78(4):353-8. PubMed ID: 12739395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
    Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
    Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical management of patients receiving haemodialysis for chronic renal failure.
    Yassin S; Ezz M
    Egypt Dent J; 1995 Oct; 41(4):1423-7. PubMed ID: 9497692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complications seen in patients undergoing intermittent haemodialysis at the Kenyatta National Hospital in the period 1984-1986.
    Mc'Ligeyo SO; Otieno LS
    East Afr Med J; 1988 Mar; 65(3):147-54. PubMed ID: 3215130
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical impact of residual function in haemodialysis.
    Carofei O; Galeotti P; Satriani M; Pedulla F; Taratufolo A
    EDTNA ERCA J; 1997; 23(3):54-6. PubMed ID: 9664012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Terminal renal failure. Rehabilitation by intermittent haemodialysis.
    Rawnsley PA
    Nurs Times; 1969 Apr; 65(14):429-32. PubMed ID: 5777052
    [No Abstract]   [Full Text] [Related]  

  • 48. Maintenance haemodialysis: patients' experiences of their life situation.
    Hagren B; Pettersen IM; Severinsson E; Lützén K; Clyne N
    J Clin Nurs; 2005 Mar; 14(3):294-300. PubMed ID: 15707439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Increased levels of total lactate dehydrogenase in isolated peripheral blood lymphocytes in patients on a chronic intermittent dialysis program].
    Matĕjcková M; Hasková V; Kaslíková J; Best'áková J
    Vnitr Lek; 1988 Oct; 34(10):974-8. PubMed ID: 3212950
    [No Abstract]   [Full Text] [Related]  

  • 50. Design and validation of a model to predict early mortality in haemodialysis patients.
    Mauri JM; Clèries M; Vela E;
    Nephrol Dial Transplant; 2008 May; 23(5):1690-6. PubMed ID: 18272779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Importance of vitamin D administration to patients under long-term intermittent dialysis].
    Revúsová V; Gratzlová J; Rezníćek J; Borosová E; Pribylincová V; Zvara V
    Vnitr Lek; 1976 Jul; 22(7):663-70. PubMed ID: 181915
    [No Abstract]   [Full Text] [Related]  

  • 53. A review of seven years' home peritoneal dialysis.
    Mion C
    Proc Eur Dial Transplant Assoc; 1981; 18():91-108. PubMed ID: 7330003
    [No Abstract]   [Full Text] [Related]  

  • 54. [Epidemiologic aspects of terminal chronic kidney failure and its therapeutic modalities].
    Prog Urol; 1996 Oct; 6(5):683-5. PubMed ID: 9102113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Long-term treatment with dialysis in chronic kidney failure using the artificial kidney Aue I].
    Lincke HU; Schröcke G
    Z Gesamte Inn Med; 1968 Oct; 23(19):592-5 passim. PubMed ID: 5702922
    [No Abstract]   [Full Text] [Related]  

  • 56. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients.
    Avci E; Coskun S; Cakir E; Kurt Y; Ozgur Akgul E; Bilgi C
    Ren Fail; 2008; 30(8):784-90. PubMed ID: 18791952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [4 years' experience in the treatment of chronic renal failure by periodic hemodialysis].
    Murisasco A; Picon G; Pollini J; de Belsunce M; Guidicelli C; Barnouin F; Fontaine G
    Mars Med; 1971; 108(1):19-29. PubMed ID: 5547840
    [No Abstract]   [Full Text] [Related]  

  • 58. [Orthostatic and clinostatic reactions in patients with chronic renal insufficiency. Before and after dialysis].
    Lisý Z
    Cas Lek Cesk; 1975 Apr; 114(16):494-500. PubMed ID: 1131839
    [No Abstract]   [Full Text] [Related]  

  • 59. [Intermittent dialysis as a treatment method in terminal renal insufficiency].
    Wijdeveld P; Dijkman J; Laar A van't ; Jansen A; van Liebergen F; Kunst V; Casparie A; Mattousch J; Flendrig J; van Laarhoven M
    Folia Med Neerl; 1966 Jul; 9(3):83-94. PubMed ID: 5920706
    [No Abstract]   [Full Text] [Related]  

  • 60. Recovery from prolonged renal failure in patients with accelerated hypertension.
    Mamdani BH; Lim VS; Mahurkar SD; Katz AI; Dunea G
    N Engl J Med; 1974 Dec; 291(25):1343-4. PubMed ID: 4427626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.